ACE2 and COVID-19: In light of the probable elevation the expression of ACE2 by these drugs, there has been growing suspicion that ACE inhibitors and Ang II receptor blockers may raise the risk of the onset and severity of COVID-19 (Al-Kuraishy et al. 2022h).